Searchable abstracts of presentations at key conferences in endocrinology

ea0081mte11 | Endocrine treatment in transgenders - when, who and how? | ECE2022

Endocrine treatment in transgenders - when, who and how?

Auer Matthias

Treatment of transgender patients has gained increasing importance in outpatient endocrinological care due to a steadily rising influx of patients in recent years. Many gaps in knowledge regarding hormonal therapy have been filled in recent years thanks to a growing body of literature based on larger cohort studies. Nowadays therapy can be regarded as safe and effective. While puberty arrest and peripubertal hormone treatment in transgender youth has gained growing acceptance ...

ea0041ep891 | Pituitary - Clinical | ECE2016

Non-alcoholic fatty liver disease in patients with biochemically cured Cushing’s disease and non-functioning pituitary adenomas: role of adrenal insufficiency and growth hormone deficiency

Auer Matthias K , Stieg Mareike R , Stalla Gunter K

Objective: Nonalcoholic fatty liver disease (NAFLD) is a hallmark of the metabolic syndrome and has been shown to be an independent predictor of cardiovascular mortality. Although glucocorticoids and growth hormone are known to be implicated in its pathophysiology, it has only rarely been investigated in the context of patients with pituitary insufficiency or former cortisol excess.Design: Case-control study, including patients with biochemically control...

ea0041ep905 | Pituitary - Clinical | ECE2016

Incidental finding of “Empty Sella” and prevalence of endocrine disturbances – a systematic review

Stieg Mareike , Auer Matthias , Stalla Gunter K , Kopczak Anna

Neuroimaging techniques have improved over the last years; hence an “empty sella” is more often incidentally diagnosed. The term “empty sella” describes a missing pituitary gland in the sella turcica. Up to now, it is not known if routine endocrine assessment is necessary in patients with primary empty sella syndrome (PES) without clinical suspicion or history of neuroendocrine disorders.We performed a systematic literature research u...

ea0032p333 | Developmental Endocrinology | ECE2013

Changes in sexual orientation in gender identity disorder: evaluation of their association to sex reassignment surgery and cross-sex hormone treatment

Auer Matthias , Fuss Johannes , Athanasoulia Anasthasia , Stalla Guenter , Sievers Caroline

Objective: Sexual orientation in males and females is considered to be determined in early life and to be virtually unchangeable in the course of adulthood. In contrast some transsexuals report a change in their sexual orientation most overt following sex reassignment procedures. The reason for this phenomenon is unknown.Methods: We asked 106 transsexual (66 MtF and 40 FtM) patients from our endocrine outpatient clinic to complete a questionnaire, retros...

ea0090rc9.4 | Rapid Communications 9: Adrenal and Cardiovascular Endocrinology 2 | ECE2023

Dysregulations in CLOCK genes in immune cells in congenital adrenal hyperplasia depending on the type of glucocorticoid replacement regimens

Ju Jing , F. Nowotny Hanna , Tschaidse Lea , Auer Matthias , Reisch Nicole

Background: Glucocorticoid (GC) substitution therapy in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH) is not able to perfectly mimic physiological circadian profiles. Unphysiologically high doses, as well as unphysiological variations in GC concentrations might cause adverSemetabolic, cardiovascular and immunological effects. Previous publications have demonstrated dysregulations in immune cell profiles of patients with primary adrenal ins...

ea0090p4 | Adrenal and Cardiovascular Endocrinology | ECE2023

Hypogonadism in men with congenital adrenal hyperplasia. A retrospective longitudinal analysis with a special focus on testicular adrenal rest tumors and 11-oxygenated androgens

Auer Matthias , Lottspeich Christian , Bidlingmaier Martin , F. Nowotny Hanna , Tschaidse Lea , Auchus Richard , Reisch Nicole

Background: Hypogonadism is frequent in men with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD). It has recently been demonstrated that testicular adrenal rest tumors (TART) are a source of 11-oxygenated androgens that might impair testicular function, in addition to their local compressive effects. Data on long-term course of testicular function in men with 21OHD and the role of potential influential factors such as presence of TART and 11-oxyge...

ea0090p287 | Adrenal and Cardiovascular Endocrinology | ECE2023

Perception of female patients with congenital adrenal hyperplasia and their parents on genital surgery: a retrospective survey

Tschaidse Lea , Sappl Andrea , Auer Matthias , Lottspeich Christian , Nowotny Hanna F. , Reisch Nicole

Background: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH) is associated with ACTH-driven adrenal androgen excess. In women with classic CAH, this regularly causes prenatal virilisation of the external genitalia, commonly corrected by genital surgery during the first years of life. This practice, however, has been questioned and is discussed highly controversial. The aim of this study was to retrospectively assess the perspective of affected patients and...

ea0090rc9.2 | Rapid Communications 9: Adrenal and Cardiovascular Endocrinology 2 | ECE2023

Frequency of stress dose adjustment and adrenal crisis in children and adults with congenital adrenal hyperplasia

Tschaidse Lea , Wimmer Sophie , Auer Matthias , Lottspeich Christian , F. Nowotny Hanna , Dubinski Ilja , Schmidt Heinrich , Quinkler Marcus , Reisch Nicole

Background: Patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH) require lifelong glucocorticoid replacement therapy, including stress dose adjustment to prevent life-threatening adrenal crises (AC). Previous studies indicate a high incidence of inadequate stress dose adjustment and AC in patients with CAH. The aim of this study was to prospectively assess AC incidence, frequency and details of stress dose adjustment as well as knowledge of the d...

ea0081oc13.3 | Oral Communications 13: Adrenal and Cardiovascular Endocrinology 2 | ECE2022

11-oxygenated C19 steroids are the predominant androgens responsible for hyperandrogenemia in Cushing’s disease

Nowotny Hanna , Vogel Frederick , Bidlingmaier Martin , Braun Leah , Reincke Martin , Tschaidse Lea , Auer Matthias , Lottspeich Christian , Hawley James M , Adaway Jo , Keevil Brian , Schilbach Katharina , Reisch Nicole

Background: Symptoms of hyperandrogenism are common in patients with Cushing’s disease (CD), but they cannot be sufficiently explained by measured concentrations of circulating androgens. In this study we analyzed the contribution of 11-oxygenated (11o×C19) androgens to hyperandrogenemia in female patients with CD as well as the influence of treatment with steroidogenesis inhibitors osilodrostat and metyrapone on 11o×C19 and classic androgens.<p class="abste...

ea0090p273 | Adrenal and Cardiovascular Endocrinology | ECE2023

Pregnancy outcomes in women with classic and non-classic congenital adrenal hyperplasia

Minea Clara , Auer Matthias , Quinkler Marcus , Meyer Gesine , Bancos Irina , Beuschlein Felix , Bothou Christina , Pivonello Rosario , Simeoli Chiara , Falhammar Henrik , Reisch Nicole

Background: There have been conflicting reports on fertility, reproduction rates and pregnancy outcomes in women with congenital adrenal hyperplasia (CAH). Identification of potential modifiable influential factors of pregnancy outcomes in these women has been hampered in the past by either small sample sizes or data derived from epidemiological samples.Methods: Retrospective multi-center study including a total number of 72 women with CAH (n=34...